The Biology and Subtypes of Mandibuloacral Dysplasia

To understand Mandibuloacral Dysplasia (MAD), it helps to look at the “scaffolding” of your body’s cells. While the condition primarily affects visible things like bone and fat, the root cause lies deep within the nucleus—the control center of your cells ^[1].

The Biology of Cellular Aging

Every cell in your body contains a protective lining called the nuclear lamina. This lining is made of proteins called lamins, which act like a structural mesh or “cage” that holds the nucleus together and keeps your DNA organized ^[2][3].

In a healthy cell, one of these proteins—lamin A—must go through a strict “processing” stage to work correctly. It starts as a precursor called prelamin A. A specific enzyme called ZMPSTE24 acts like a pair of biological scissors, snipping off a small piece of the prelamin A to create the finished, mature lamin A ^[2][4].

In classic MAD, this process is disrupted in several ways, depending on which gene is affected. This disruption weakens the cell’s scaffolding, leading to the symptoms of early tissue changes and altered body structure ^[1][4].

Subtype A: The LMNA Gene (MADA)

MADA is the most common classic form and is caused by mutations in the LMNA gene ^[5]. In this subtype, the body has the “scissors” to process the protein, but the protein itself (the lamin A) is built with a flaw ^[3].

• Lipodystrophy Pattern: This subtype is typically associated with partial lipodystrophy. This means fat loss predominantly affects certain regions, often the arms and legs (the extremities), while it may stay the same or even increase around the neck and face ^[5][1].
• Key Biological Feature: Research shows that in MADA, the nucleus often becomes misshapen, and the cell’s internal clock speeds up, causing it to enter a state of “senescence” (old age) much earlier than normal ^[3][6].

Subtype B: The ZMPSTE24 Gene (MADB)

MADB occurs when there is a problem with the “scissors” (ZMPSTE24) rather than the protein itself ^[7]. Because the enzyme cannot do its job, the “unfinished” version of the protein (prelamin A) builds up inside the cell ^[8][4].

• Lipodystrophy Pattern: MADB often leads to generalized lipodystrophy, where fat loss is reported more broadly across the whole body rather than just in the limbs ^[7][1].
• Key Biological Feature: The buildup of unprocessed prelamin A is toxic to the cell. Interestingly, the severity of the disease often depends on how much “scissor” activity is left; if the enzyme still works a little bit, the symptoms are usually those of MAD, but if it doesn’t work at all, it can lead to a more severe condition called restrictive dermopathy ^[9][10].

The Emerging “MADaM” Phenotype (MTX2 Gene)

Scientists have recently identified other genes that cause very similar symptoms, sometimes called phenocopies. A third variation, often called MADaM (Mandibuloacral Dysplasia associated with Mitochondrial dysfunction), is linked to the MTX2 gene ^[11][12].

• Biological Mechanism: In this subtype, based on a very small emerging literature, mutations in the MTX2 gene are reported to impair the mitochondria, which are the cell’s “power plants” ^[11].
• Clinical Presentation: This form is often more severe and has been reported to involve generalized lipodystrophy and complications like high blood pressure and kidney issues at a very young age ^[11][13].

Classification at a Glance

Understanding which subtype you have is essential because it helps your medical team predict which organ systems—such as your metabolic health or your kidneys—may need the most attention, although monitoring always depends on your actual findings as well as the gene ^[12].